1. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Issue 7 (July 2016) Authors: Goldberg, Sarah B; Gettinger, Scott N; Mahajan, Amit; Chiang, Anne C; Herbst, Roy S; Sznol, Mario; Tsiouris, Apostolos John; Cohen, Justine; Vortmeyer, Alexander; Jilaveanu, Lucia; Yu, James; Hegde, Upendra; Speaker, Stephanie; Madura, Matthew; Ralabate, Amanda; Rivera, Angel; Rowen, Elin; Gerris... Journal: Lancet oncology Issue: Volume 17:Issue 7(2016:Jul.) Page Start: 976 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. (December 2018) Authors: McDermott, David; Huseni, Mahrukh; Atkins, Michael; Motzer, Robert; Rini, Brian; Escudier, Bernard; Fong, Lawrence; Joseph, Richard; Pal, Sumanta; Reeves, James; Sznol, Mario; Hainsworth, John; Rathmell, W.; Stadler, Walter; Hutson, Thomas; Gore, Martin; Ravaud, Alain; Bracarda, Sergio; Suárez, C... Journal: Nature medicine Issue: Volume 24:Number 12(2018) Page Start: 1941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RBTT-07. A PHASE 2 TRIAL OF PEMBROLIZUMAB AND BEVACIZUMAB IN MELANOMA BRAIN MET PATIENTS. (11th November 2019) Authors: Kluger, Harriet M; Forsyth, Peter; Khushalani, Nikhil; Eroglu, Zeynep; Sznol, Mario; Tran, Thuy; Jilaveanu, Lucia; Cohen, Justine V; Hegde, Upendra; Wei, Wei; Mahajan, Amit; Goldberg, Sarah B; Chiang, Veronica; Weiss, Sarah A Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study. (10th December 2020) Authors: Diab, Adi; Tykodi, Scott; Daniels, Gregory; Maio, Michele; Curti, Brendan; Lewis, Karl; Jang, Sekwon; Kalinka, Ewa; Puzanov, Igor; Spira, Alexander; Cho, Daniel; Guan, Shanhong; Puente, Erika; Hoch, Ute; Currie, Sue; Nguyen, Tuan; Lin, Wei; Tagliaferri, Mary; Zalevsky, Jonathan; Sznol, Mario Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study. (9th November 2020) Authors: Diab, Adi; Tykodi, Scott; Daniels, Gregory; Maio, Michele; Curti, Brendan; Lewis, Karl; Jang, Sekwon; Kalinka, Ewa; Puzanov, Igor; Spira, Alexander; Cho, Daniel; Guan, Shanhong; Puente, Erika; Hoch, Ute; Currie, Sue; Nguyen, Tuan; Lin, Wei; Tagliaferri, Mary; Zalevsky, Jonathan; Sznol, Mario Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 21 Plasma-based proteomic profiling as a tool for predicting response to immunotherapy in melanoma patients. (10th December 2020) Authors: Harel, Michal; Lahav, Coren; Jacob, Eyal; Issler, Eran; Bar, Haim; Dicker, Adam; Sharon, Ofer; Bacchiocchi, Antonietta; Halaban, Ruth; Sznol, Mario; Shaked, Yuval Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 21 Plasma-based proteomic profiling as a tool for predicting response to immunotherapy in melanoma patients. (9th November 2020) Authors: Harel, Michal; Lahav, Coren; Jacob, Eyal; Issler, Eran; Bar, Haim; Dicker, Adam; Sharon, Ofer; Bacchiocchi, Antonietta; Halaban, Ruth; Sznol, Mario; Shaked, Yuval Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218). Issue 1 (23rd November 2020) Authors: Hodi, F. Stephen; Chapman, Paul B.; Sznol, Mario; Lao, Christopher D.; Gonzalez, Rene; Smylie, Michael; Daniels, Gregory A.; Thompson, John A.; Kudchadkar, Ragini; Sharfman, William; Atkins, Michael; Spigel, David R.; Pavlick, Anna; Monzon, Jose; Kim, Kevin B.; Ernst, Scott; Khushalani, Nikhil I.... Journal: Melanoma research Issue: Volume 31:Issue 1(2021) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tissue resident memory T cells create genetically distinct immune microenvironments within melanoma metastasis. (4th November 2015) Authors: Dhodapkar, Kavita; Bar, Noffar; Boddupalli, Chandra Sekhar; Kadaveru, Krishna; Mai, Zifeng; Deng, Yanhong; Sznol, Mario; Dhodapkar, Madhav Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pre-treatment patient selection for nivolumab benefit based on serum mass spectra. (4th November 2015) Authors: Weber, Jeffrey; Martinez, Alberto J; Roder, Heinrich; Roder, Joanna; Meyer, Krista; Asmellash, Senait; Grigorieva, Julia; Tsypin, Maxim; Oliveira, Carlos; Steingrimsson, Arni; Sayers, Kevin; Bacchiocchi, Antonella; Sznol, Mario; Halaban, Ruth; Kluger, Harriet Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗